The Chemours Company (CC) reported a fourth-quarter net loss of $47 million or $0.31 per share, compared with a net loss of $11 million or $0.08 per share in the corresponding prior-year quarter.
Adjusted net Income was $7 million or $0.05 per share, compared to adjusted net income of $14 million or $0.09 per share in the corresponding prior-year quarter.
Net sales were $1.33 billion, slightly down from $1.36 billion compared to the corresponding prior-year quarter.
Looking forward to the first quarter, the Company anticipates consolidated Net Sales to increase in the range of 3 to 5% sequentially, driven by TSS, with consolidated Adjusted EBITDA expected to range between $120 million and $150 million.
For the full year 2026, the company expects to deliver 2026 net sales growth in the range of 3 to 5% and adjusted EBITDA of $800 million to $900 million.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.